These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28823853)

  • 1. Distribution of fluorescein sodium and triamcinolone acetonide in the simulated liquefied and vitrectomized Vitreous Model with simulated eye movements.
    Stein S; Bogdahn M; Rosenbaum C; Weitschies W; Seidlitz A
    Eur J Pharm Sci; 2017 Nov; 109():233-243. PubMed ID: 28823853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal pharmacokinetics after posterior subtenon triamcinolone acetonide injection in vitrectomized rabbit eyes.
    Park HJ; Lee JE; Kim SI; Pak KY; Oum BS; Lee JS; Jung JH; Lee JE
    Retina; 2014 Apr; 34(4):801-6. PubMed ID: 24077088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes.
    Chin HS; Park TS; Moon YS; Oh JH
    Retina; 2005; 25(5):556-60. PubMed ID: 16077349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection.
    Inoue M; Takeda K; Morita K; Yamada M; Tanigawara Y; Oguchi Y
    Am J Ophthalmol; 2004 Dec; 138(6):1046-8. PubMed ID: 15629301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vitreous liquefaction on the intravitreal distribution of sodium fluorescein, fluorescein dextran, and fluorescent microparticles.
    Tan LE; Orilla W; Hughes PM; Tsai S; Burke JA; Wilson CG
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1111-8. PubMed ID: 20881289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulation of drug distribution in the vitreous body after local drug application into intact vitreous body and in progress of posterior vitreous detachment.
    Loch C; Bogdahn M; Stein S; Nagel S; Guthoff R; Weitschies W; Seidlitz A
    J Pharm Sci; 2014 Feb; 103(2):517-26. PubMed ID: 24311438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the test method on in vitro drug release from intravitreal model implants containing dexamethasone or fluorescein sodium in poly (d,l-lactide-co-glycolide) or polycaprolactone.
    Stein S; Auel T; Kempin W; Bogdahn M; Weitschies W; Seidlitz A
    Eur J Pharm Biopharm; 2018 Jun; 127():270-278. PubMed ID: 29490233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal triamcinolone acetonide concentration after subtenon injection.
    Thomas ER; Wang J; Ege E; Madsen R; Hainsworth DP
    Am J Ophthalmol; 2006 Nov; 142(5):860-1. PubMed ID: 17056371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes.
    Mason JO; Somaiya MD; Singh RJ
    Retina; 2004 Dec; 24(6):900-4. PubMed ID: 15579987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
    Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
    Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic study of vitreous and serum concentrations of triamcinolone acetonide after posterior sub-tenon's injection.
    Kovacs K; Wagley S; Quirk MT; Ceron OM; Silva PA; Singh RJ; Gukasyan HJ; Arroyo JG
    Am J Ophthalmol; 2012 May; 153(5):939-48. PubMed ID: 22310078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitreous concentration of triamcinolone acetonide after a single transseptal depot injection.
    Silva PS; Singh RJ; Bakri SJ; Lising RS; Santiago DE; Uy HS
    Ocul Immunol Inflamm; 2009; 17(3):216-20. PubMed ID: 19585367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye.
    Kosobucki BR; Freeman WR; Cheng L
    Br J Ophthalmol; 2006 Jun; 90(6):705-8. PubMed ID: 16531422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epiretinal deposit of triamcinolone acetonide at the posterior pole after intravitreal injection.
    Jaissle GB; Szurman P; Völker M; Bartz-Schmidt KU
    Ophthalmic Surg Lasers Imaging; 2007; 38(3):238-41. PubMed ID: 17552392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
    Kamppeter BA; Cej A; Jonas JB
    Ophthalmology; 2008 Aug; 115(8):1372-5. PubMed ID: 18355920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution, release kinetics, and biocompatibility of triamcinolone injected and dispersed in silicone oil.
    Spitzer MS; Kaczmarek RT; Yoeruek E; Petermeier K; Wong D; Heimann H; Jaissle GB; Bartz-Schmidt KU; Szurman P
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2337-43. PubMed ID: 19098319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection.
    Beer PM; Bakri SJ; Singh RJ; Liu W; Peters GB; Miller M
    Ophthalmology; 2003 Apr; 110(4):681-6. PubMed ID: 12689886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes.
    Yi NY; Davis JL; Salmon JH; Gilger BC
    Vet Ophthalmol; 2008 Sep; 11 Suppl 1():15-9. PubMed ID: 19046265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.